Correlation Between Enliven Therapeutics and Inventiva

Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enliven Therapeutics and Inventiva Sa, you can compare the effects of market volatilities on Enliven Therapeutics and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Inventiva.

Diversification Opportunities for Enliven Therapeutics and Inventiva

0.31

Correlation Coefficient

Enliven Therapeutics  Inventiva

Weak diversification

The 3 months correlation between Enliven and Inventiva is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Inventiva go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Inventiva

Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 2.09 times less return on investment than Inventiva. But when comparing it to its historical volatility, Enliven Therapeutics is 2.36 times less risky than Inventiva. It trades about 0.07 of its potential returns per unit of risk. Inventiva Sa is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  233.00  in Inventiva Sa on September 3, 2024 and sell it today you would earn a total of  32.00  from holding Inventiva Sa or generate 13.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Enliven Therapeutics  vs.  Inventiva Sa

Enliven Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Inventiva Sa

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Inventiva Sa are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Inventiva sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enliven Therapeutics and Inventiva

The main advantage of trading using opposite Enliven Therapeutics and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.

The idea behind Enliven Therapeutics and Inventiva Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.